{
  "id": "20398b71bf06cd5e",
  "title": "STAT+: Lawsuit against Hims & Hers should be \u2018wake-up call\u2019 for compounders, Novo chief counsel says",
  "description": "Novo's chief counsel says telehealth companies and compounding pharmacies that are continuing to make copycat versions of Wegovy \u201cshould be very, very much on notice.\u201d",
  "content": "Novo's chief counsel says telehealth companies and compounding pharmacies that are continuing to make copycat versions of Wegovy \u201cshould be very, very much on notice.\u201d",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/02/09/hims-novo-lawsuit-chief-counsel-interview/?utm_campaign=rss",
  "published_at": "2026-02-09T14:13:34+00:00",
  "fetched_at": "2026-02-10T00:34:54.529614+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Lawsuit against Hims & Hers should be \u2018wake-up call\u2019 for compounders, Novo chief counsel says",
    "description": "Novo's chief counsel says telehealth companies and compounding pharmacies that are continuing to make copycat versions of Wegovy \u201cshould be very, very much on notice.\u201d",
    "url": "https://www.statnews.com/pharmalot/2026/02/09/hims-novo-lawsuit-chief-counsel-interview/?utm_campaign=rss",
    "published": "2026-02-09T14:13:34+00:00",
    "source": "STAT"
  }
}